XML 50 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE
6 Months Ended
Dec. 31, 2019
Receivables [Abstract]  
NOTE 3 - ACCOUNTS RECEIVABLE. MEDICAL RECEIVABLES AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)

 FONAR CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2019 and 2018

(Amounts and shares in thousands, except per share amounts)

(UNAUDITED)

  

NOTE 3 – ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE

 

Receivables, net is comprised of the following at December 31, 2019, and June 30, 2019:

 

   December 31, 2019
   Gross Receivable  Allowance for doubtful accounts  Net
Accounts receivable  $4,318   $190   $4,128 
Accounts receivable - related party  $60    —     $60 
Medical receivable  $16,151   $—     $16,151 
Management and other fees receivable  $35,884   $8,602   $27,282 
Management and other fees receivable from related medical practices ("PC’s")  $9,129   $2,116   $7,013 

 

 

   June 30, 2019
   Gross Receivable  Allowance for doubtful accounts  Net
Accounts receivable  $3,927   $190   $3,737 
Accounts receivable - related party  $—      —     $—   
Medical receivable  $15,729   $—     $15,729 
Management and other fees receivable  $35,114   $9,405   $25,709 
Management and other fees receivable from related medical practices ("PC’s")  $8,812   $2,311   $6,501 

 

The Company's customers are concentrated in the healthcare industry.

 

Accounts Receivable

 

Credit risk with respect to the Company’s accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.

  

Long Term Accounts Receivable

 

The Company generated revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be received over the next four years at December 31, 2019 are as follows:

 

2021   $619 
2022    619 
2023    619 
2024    464 
Total   $2,321 

Medical Receivables

Medical receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs, patient’s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The carrying amount of the medical receivable is reduced by an allowance that reflects management’s best estimate of the amounts that will not be collected. The Company continuously monitors collections from its clients and maintains an allowance for bad debts based upon the Company’s historical collection experience. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings, specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.

 

Management and Other Fees Receivable

 

The Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding under management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement organizations, principally insurance companies and health management organizations.

 

Payment of the management fee receivables from the PC’s may be impaired by the inability of the PC’s to collect in a timely manner their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately 60% and 66% of the PCs’ net revenues for the three months ended December 31, 2019 and 2018, respectively, were derived from no-fault and personal injury protection claims. Approximately 63% and 67% of the PCs’ net revenues for the six months ended December 31, 2019 and 2018, respectively, were derived from no-fault and personal injury protection claims. The Company considers the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes all legally available steps to collect its receivables. Credit losses associated with the receivables are provided for in the condensed consolidated financial statements and have historically been within management's expectations.

 

Net revenues from management and other fees charged to the related PCs accounted for approximately 11.1% and 10.8% of the consolidated net revenues for the three months ended December 31, 2019 and 2018, respectively. Net revenues from management and other fees charged to the related PCs accounted for approximately 11.1% and 10.9% of the consolidated net revenues for the six months ended December 31, 2019 and 2018, respectively.

 

Tallahassee Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI & Diagnostic Center, PA (all related medical practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement, pursuant to which management fees are payable to the Company.

 

The Company’s patient fee revenue, net of contractual allowances and discounts for the three and six months ended December 31, 2019 and 2018 are summarized in the following table.

 

   For the Three Months Ended
December 31,
   2019  2018
Commercial Insurance/ Managed Care  $1,335   $1,335 
Medicare/Medicaid   276    270 
Workers' Compensation/Personal Injury   4,112    3,956 
Other   273    360 
Patient Fee Revenue, net of contractual allowances and discounts  $5,996   $5,921 

 

 

   For the Six Months Ended
December 31,
   2019  2018
Commercial Insurance/ Managed Care  $2,689   $2,515 
Medicare/Medicaid   542    561 
Workers' Compensation/Personal Injury   8,406    7,658 
Other   404    712 
Patient Fee Revenue, net of contractual allowances and discounts  $12,041   $11,446